University of Rochester Leads Gilead Drug Study of GS-6615 for LQT3
A team of scientists at the University of Rochester Medical Center is spearheading a global drug study for patients diagnosed with Long QT Syndrome, a hereditary cardiac rhythm disorder. The ... Read more